Table 2 Two marker haplotype frequencies, transmission, and association statistics for CARD4 (caspase recruitment domain family, member 4) in inflammatory bowel diseases.
Variation | Haplotype* | fcontrols† | fcases† | p Value‡ | fT§ | fNT§ | p Value¶ | D′** |
---|---|---|---|---|---|---|---|---|
rs2075822 + ND1+32656 | 1 – 1 | 0.771 | 0.762 | 0.846 | 0.455 | 0.486 | 0.094 | 0.91 |
1 – 2 | 0.042 | 0.040 | 0.140 | 0.101 | ||||
2 – 1 | 0.013 | 0.015 | 0.026 | 0.057 | ||||
2 – 2 | 0.174 | 0.184 | 0.380 | 0.357 | ||||
ND1+32656 + rs2907748 | 1 – 1 | 0.784 | 0.775 | 0.727 | 0.473 | 0.519 | 0.719 | 0.98 |
1 – 2 | 0.002 | 0.002 | 0.011 | 0.011 | ||||
2 – 1†† | 0.006 | 0.004 | 0.014 | 0.008 | ||||
2 – 2 | 0.208 | 0.220 | 0.503 | 0.462 |
*Allele 1 is defined as the major allele.
†Frequencies of haplotypes in cases and controls estimated by the expectation maximisation algorithm using COCAPHASE.[6]
‡Global significance value obtained after 10 000 permutations with COCAPHASE.
§Frequencies of transmitted (fT) and non‐transmitted (fNT) haplotypes observed using TDTPHASE.[6]
¶Global significance value obtained after 10 000 permutations with TDTPHASE.
**D′ value as a measure of linkage disequilibrium in the control sample.
††Protective haplotype previously identified by McGovern and colleagues.[2]